Key facts
- This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2025, 21:35.
Jonathan Sheena - 31 Jan 2025 Form 4 Insider Report for Natera, Inc. (NTRA)
- Reporting relationship
- Director, CO-FOUNDER
- Issuer ticker
- NTRA
- Reported as of
- 31 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2025, 21:35:15 UTC
- Prior SEC filing
- 31 Jan 2025
- Next SEC filing
- 28 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tami Chen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Sheena filed Form 4 for Natera, Inc. (NTRA) on 04 Feb 2025.
Change
- Previous filing in this sequence was filed on 31 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NTRA
transaction
Common Stock
Award
- Transaction value
- Shares
- +3,549
- Change %
- +1.4%
- Price
- Shares after
- 263,489
- Date
- 31 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
NTRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 44,782
- Date
- 31 Jan 2025
- Ownership
- By Caraluna 1 Trust
- Footnotes
- F3
NTRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 44,782
- Date
- 31 Jan 2025
- Ownership
- By Caraluna 2 Trust
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 31, 2026 and the remaining RSUs vest in 12 equal quarterly installments thereafter.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F3
Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.